Oppenheimer Asset Management Inc. Bio Techne Corp Transaction History

Oppenheimer Asset Management Inc.

$7.94 Billion
Q4 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 64,237 shares of TECH stock, worth $3.89 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

64,237

Previous 67,378 4.66%

Holding current value

$3.89 Million

Previous $5.38 Million 14.08%

% of portfolio

0.06%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$66.37 - $78.17 $208,468 - $245,531	-3,141 Reduced 4.66%	64,237 $4.63 Million
Q3 2024 Nov 05, 2024	SELL	$70.96 - $82.35 $59,322 - $68,844	-836 Reduced 1.23%	67,378 $5.38 Million
Q2 2024 Aug 08, 2024	BUY	$62.12 - $84.15 $223,942 - $303,360	3,605 Added 5.58%	68,214 $4.89 Million
Q1 2024 May 06, 2024	BUY	$65.98 - $77.09 $133,015 - $155,413	2,016 Added 3.22%	64,609 $4.55 Million
Q4 2023 Feb 13, 2024	SELL	$52.83 - $78.22 $36,452 - $53,971	-690 Reduced 1.09%	62,593 $4.83 Million
Q3 2023 Nov 07, 2023	BUY	$67.52 - $89.42 $42,267 - $55,976	626 Added 1.0%	63,283 $4.31 Million
Q2 2023 Aug 02, 2023	SELL	$73.76 - $85.98 $75,087 - $87,527	-1,018 Reduced 1.6%	62,657 $5.11 Million
Q1 2023 May 10, 2023	BUY	$71.62 - $86.62 $194,806 - $235,606	2,720 Added 4.46%	63,675 $4.72 Million
Q4 2022 Feb 06, 2023	BUY	$80.67 - $352.29 $3.64 Million - $15.9 Million	45,119 Added 284.91%	60,955 $5.05 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $92,108 - $127,743	-326 Reduced 2.02%	15,836 $4.5 Million
Q2 2022 Aug 08, 2022	SELL	$322.67 - $449.65 $176,823 - $246,408	-548 Reduced 3.28%	16,162 $5.6 Million
Q1 2022 May 12, 2022	SELL	$353.85 - $487.79 $257,248 - $354,623	-727 Reduced 4.17%	16,710 $7.24 Million
Q4 2021 Feb 02, 2022	BUY	$456.15 - $525.06 $12,316 - $14,176	27 Added 0.16%	17,437 $9.02 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $379,029 - $459,125	-852 Reduced 4.67%	17,410 $8.44 Million
Q2 2021 Aug 03, 2021	SELL	$387.35 - $450.26 $144,481 - $167,946	-373 Reduced 2.0%	18,262 $8.22 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $767,358 - $1 Million	-2,439 Reduced 11.57%	18,635 $7.12 Million
Q4 2020 Feb 11, 2021	BUY	$246.9 - $321.87 $5,184 - $6,759	21 Added 0.1%	21,074 $6.69 Million
Q3 2020 Nov 13, 2020	BUY	$232.22 - $282.96 $45,747 - $55,743	197 Added 0.94%	21,053 $5.22 Million
Q2 2020 Aug 11, 2020	BUY	$185.43 - $279.56 $46,357 - $69,890	250 Added 1.21%	20,856 $5.51 Million
Q1 2020 May 08, 2020	BUY	$161.17 - $221.51 $279,791 - $384,541	1,736 Added 9.2%	20,606 $3.91 Million
Q4 2019 Feb 07, 2020	SELL	$189.68 - $222.09 $10,053 - $11,770	-53 Reduced 0.28%	18,870 $4.14 Million
Q3 2019 Oct 31, 2019	SELL	$183.56 - $216.72 $58,372 - $68,916	-318 Reduced 1.65%	18,923 $3.7 Million
Q2 2019 Aug 09, 2019	BUY	$188.72 - $215.43 $49,067 - $56,011	260 Added 1.37%	19,241 $4.01 Million
Q1 2019 Apr 24, 2019	BUY	$136.09 - $200.44 $96,215 - $141,711	707 Added 3.87%	18,981 $3.77 Million
Q4 2018 Jan 30, 2019	BUY	$132.75 - $203.8 $78,588 - $120,649	592 Added 3.35%	18,274 $2.64 Million
Q3 2018 Oct 26, 2018	BUY	$147.44 - $204.11 $303,873 - $420,670	2,061 Added 13.19%	17,682 $3.61 Million
Q2 2018 Aug 10, 2018	BUY	$144.9 - $165.58 $256,762 - $293,407	1,772 Added 12.8%	15,621 $2.31 Million
Q1 2018 May 09, 2018	BUY	$131.46 - $151.04 $219,406 - $252,085	1,669 Added 13.7%	13,849 $2.09 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $1.38 Million - $1.51 Million	12,180	12,180 $1.47 Million

Others Institutions Holding TECH

# of Institutions

618

Shares Held

156M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.38B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Bio Techne Corp Transaction History